| |
| |
|
| Insider
Information: |
Lechleiter John C |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
637,806 |
|
|
Indirect Shares
|
552,256 |
|
|
| Direct
Value |
$345,325,032 |
|
|
|
Indirect Value
|
$425,855,647 |
|
|
| Total
Shares |
1,190,062 |
|
|
| Total
Value |
$771,180,679 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 18.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
former director |
2017-05-25 |
436,161 |
2017-05-25 |
552,256 |
Premium* |
|
|
Nike Inc B |
NKE |
Director |
2019-07-26 |
81,645 |
2010-04-28 |
0 |
Premium* |
|
|
Ford Motor Co |
F |
Director |
2020-03-16 |
120,000 |
2013-11-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
201 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
EVP, Pharma Prod./Corp. Dev. |
• – – |
2003-07-09 |
4 |
OE |
$14.66 |
$369,076 |
D/D |
25,180 |
89,578 |
|
- |
|
| LLY |
Eli Lilly & Co |
EVP, Pharmaceutical Operations |
• – – |
2003-12-17 |
5 |
GD |
$0.00 |
$0 |
D/D |
557 |
89,021 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP, Pharmaceutical Operations |
• – – |
2003-12-18 |
5 |
GD |
$0.00 |
$0 |
D/D |
523 |
88,498 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP, Pharmaceutical Operations |
• – – |
2003-12-22 |
5 |
GD |
$0.00 |
$0 |
D/D |
1,875 |
86,623 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP, Pharmaceutical Operations |
• – – |
2004-06-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
761 |
113,590 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP, Pharmaceutical Operations |
• – – |
2004-07-08 |
4 |
OE |
$23.41 |
$649,043 |
D/D |
27,728 |
114,351 |
|
- |
|
| LLY |
Eli Lilly & Co |
EVP, Pharmaceutical Operations |
• – – |
2004-09-09 |
5 |
GD |
$0.00 |
$0 |
D/D |
310 |
113,280 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP, Pharmaceutical Operations |
• – – |
2005-01-14 |
4 |
A |
$56.79 |
$795,060 |
D/D |
14,000 |
128,351 |
|
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2005-03-17 |
5 |
GA |
$0.00 |
$0 |
I/I |
4,576 |
12,646 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2005-03-17 |
5 |
GD |
$0.00 |
$0 |
D/D |
4,576 |
122,704 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2005-11-22 |
5 |
GA |
$0.00 |
$0 |
D/D |
3,200 |
125,904 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2005-11-22 |
5 |
GD |
$0.00 |
$0 |
I/I |
3,200 |
9,446 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2005-12-14 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,977 |
122,927 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2005-12-21 |
5 |
GD |
$0.00 |
$0 |
D/D |
81 |
122,846 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
officerTitle |
• • – |
2006-01-20 |
4 |
A |
$57.04 |
$1,844,959 |
D/D |
32,345 |
155,191 |
|
- |
|
| LLY |
Eli Lilly & Co |
officerTitle |
• • – |
2006-02-01 |
4 |
D |
$56.62 |
$243,126 |
D/D |
(4,294) |
150,897 |
|
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2006-07-31 |
4 |
AS |
$56.51 |
$1,412,750 |
D/D |
(25,000) |
125,897 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2006-09-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,049 |
124,848 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2006-09-15 |
4 |
D |
$55.11 |
$564,421 |
D/D |
(10,240) |
127,718 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2006-09-15 |
4 |
OE |
$34.60 |
$453,540 |
D/D |
13,110 |
137,958 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2006-10-23 |
4 |
AS |
$56.87 |
$1,421,750 |
D/D |
(25,000) |
102,718 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2006-11-09 |
5 |
GA |
$0.00 |
$0 |
I/I |
287 |
775 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2006-11-09 |
5 |
GD |
$0.00 |
$0 |
D/D |
467 |
102,251 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2006-11-10 |
5 |
GD |
$0.00 |
$0 |
D/D |
186 |
102,065 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
President and COO |
• • – |
2006-11-10 |
5 |
GA |
$0.00 |
$0 |
I/I |
2 |
777 |
0 |
- |
|
201 Records found
|
|
Page 1 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
